T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNCL
576
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $122M | 0.02% |
7,328,533
+3,500
| +0% | +$53.4K |
|
577
Match Group
MTCH
$8.48B
| $120M | 0.02% |
5,183,158
+54,090
| +1% | +$1.09M |
|
578
Steris
STE
$23B
| $120M | 0.02% |
1,353,023
-170,087
| -11% | -$14.4M |
|
579
Twilio
TWLO
$38.9B
| $119M | 0.02% |
3,991,105
-2,708,509
| -40% | -$81.2M |
|
580
Brink's
BCO
$4.71B
| $119M | 0.02% |
1,407,628
-275,928
| -16% | -$21M |
|
|
HPP
581
Hudson Pacific Properties
HPP
$789M
| $118M | 0.02% |
501,885
+64,619
| +15% | +$14.7M |
|
|
B
582
DELISTED
Barnes Group Inc.
B
| $118M | 0.02% |
1,671,614
+313,972
| +23% | +$19.5M |
|
|
XLRN
583
DELISTED
Acceleron Pharma
XLRN
| $118M | 0.02% |
3,153,619
-693,288
| -18% | -$24.1M |
|
584
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.43B
| $117M | 0.02% |
4,819,166
-40,470
| -0.8% | -$947K |
|
585
Live Oak Bancshares
LOB
$1.99B
| $117M | 0.02% |
5,001,263
+688,113
| +16% | +$16.1M |
|
586
Infosys
INFY
$50.2B
| $117M | 0.02% |
16,062,152
-2,431,604
| -13% | -$18.4M |
|
587
Xcel Energy
XEL
$49.2B
| $117M | 0.02% |
2,472,934
-2,427,439
| -50% | -$116M |
|
588
Haemonetics
HAE
$4.12B
| $117M | 0.02% |
2,604,262
-625,424
| -19% | -$26M |
|
589
Agios Pharmaceuticals
AGIO
$2.01B
| $117M | 0.02% |
1,747,136
+245,605
| +16% | +$14.8M |
|
|
PXD
590
DELISTED
Pioneer Natural Resource Co.
PXD
| $116M | 0.02% |
786,415
-697,278
| -47% | -$100M |
|
591
National Bank Holdings
NBHC
$1.94B
| $116M | 0.02% |
3,239,234
+21,270
| +0.7% | +$705K |
|
|
WRK
592
DELISTED
WestRock Company
WRK
| $115M | 0.02% |
2,034,108
-135,698
| -6% | -$7.75M |
|
593
FIVE9
FIVN
$2.5B
| $114M | 0.02% |
4,773,024
+733,129
| +18% | +$15.9M |
|
594
Zillow
Z
$8.09B
| $114M | 0.02% |
2,832,501
-510,840
| -15% | -$21.6M |
|
595
Columbia Banking Systems
COLB
$9.15B
| $114M | 0.02% |
2,700,054
-21,800
| -0.8% | -$843K |
|
596
Xencor
XNCR
$1.72B
| $113M | 0.02% |
4,940,037
+1,206,539
| +32% | +$26.8M |
|
597
Hope Bancorp
HOPE
$1.84B
| $113M | 0.02% |
6,392,009
+188,495
| +3% | +$3.22M |
|
|
INVX
598
Innovex International
INVX
$2.15B
| $113M | 0.02% |
2,554,044
+568,970
| +29% | +$24.8M |
|
599
Portland General Electric
POR
$5.92B
| $113M | 0.02% |
2,468,060
-1,097,855
| -31% | -$50.6M |
|
|
CLVS
600
DELISTED
Clovis Oncology, Inc.
CLVS
| $111M | 0.02% |
1,352,705
-680,558
| -33% | -$54M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.